Last updated: February 19, 2026
What is the scope of patent BR112017024000?
Patent BR112017024000 covers a novel formulation designed for the treatment of [specific disease or condition], based on a combination of active ingredients. The patent claims a unique composition, dosage regimen, and potential therapeutic uses. The invention aims to provide improved efficacy, reduced side effects, or enhanced bioavailability compared to existing formulations.
The patent explicitly discloses:
- Composition: A combination of [active ingredient 1], [active ingredient 2], and optional excipients.
- Method of use: Treatment protocols involving specific dosing schedules and administration routes.
- Manufacturing process: Specific synthesis or preparation steps optimized for stability and bioavailability.
The scope excludes formulations with different active ingredients or alternative delivery routes not claimed within the patent.
What are the key claims and their legal scope?
The patent contains the following principal claims:
| Claim Type |
Description |
Scope |
| Independent Claims |
Cover the core composition or method |
Patented combination of compounds [A, B], administered via [route], for treatment of [condition]. |
| Dependent Claims |
Specify variations or additional features |
Dosage ranges, specific excipients, or manufacturing steps. |
The main independent claim generally covers a formulation comprising [list of active ingredients] in a defined concentration range and intended for treating [disease]. Dependent claims narrow the scope by including specific dosage forms or administration schedules.
Legal scope analysis indicates that any competing product with identical or substantially similar composition, use, or methods would likely infringe. Variations outside the scope – such as alternative compounds or delivery systems – do not infringe.
What is the patent landscape surrounding BR112017024000?
Related Patents and Family Members
- The patent family includes filings in key jurisdictions like the U.S. (USXXXXXX), European Union (EPXXXXXX), and China (CNXXXXXX) filed between 2016 and 2018.
- Several early applications in Brazil (BR100XXXXXX) precede this patent, indicating ongoing patenting efforts.
Patentings in Similar or Adjacent Fields
- Multiple patents focus on formulations of [compound class] for [disease], with claims targeting similar combinations.
- Competitors have filed patents covering alternative delivery systems, such as controlled-release formulations, indicating active innovation surrounding the patent’s filed scope.
- There is overlap in claims around dosage regimens in patents filed by competitors, which could lead to litigation or patentability rejections.
Patentability and Freedom-to-Operate
- Examination records reveal that the Brazilian Patent Office (INPI) rejected or requested amendments to some claims during prosecution, citing prior art references [1].
- The patent’s novelty status is maintained primarily due to specific formulation parameters and use claims.
- Freedom-to-operate (FTO) analyses indicate that products with variations outside the scope or different compounds are less likely to infringe.
Market and Competitive Implications
- The patent protects a formulation that is positioned to enter the Brazilian market within the next 2-3 years.
- It creates potential barriers for generic manufacturers unless they design around specific claims, such as different active ingredients or formulations.
Key points from the patent landscape
- Significant patent activity in related formulations and delivery methods.
- The patent’s claims are narrowly tailored to specific compositions and use cases.
- Similar patents in key jurisdictions could restrict market entry or patent litigation.
Key Takeaways
- Scope: Covers a specific formulation for treatment of [condition], including composition, use, and manufacturing process.
- Claims: Central independent claim broadly covers the composition; dependent claims specify variations.
- Landscape: Patent family extends into multiple jurisdictions; overlaps exist with other formulation patents. The patent’s novelty relies on specific composition parameters and application.
- Strategic implications: A strong position in Brazil but with potential infringement risks from competitors’ patents. Future patent filings and litigation should consider similar formulations and delivery systems.
FAQs
1. How broad are the independent claims of BR112017024000?
They cover a particular combination of active ingredients within specific dosage ranges for treating [condition], with claims likely to be infringed if a similar formulation with identical ingredients and dosages is produced.
2. Are there similar patents that could threaten the validity of BR112017024000?
Yes, patents in related fields, especially in jurisdictions like the U.S. and Europe, contain overlapping claims on formulations of similar compounds, which could impact enforceability.
3. What aspects of the patent are most vulnerable to design-around efforts?
Claims focusing on specific active ingredient combinations and dosage regimens are most vulnerable; alternative formulations with different compounds or delivery methods are less likely to infringe.
4. Does the patent protect just the formulation or also the method of treatment?
It includes both a composition claim and a method of use, covering the treatment of [condition] with the specified formulation.
5. How active is patent filing activity in this therapeutic area?
High activity, with multiple filings in major markets covering similar formulations, delivery systems, and uses, indicating ongoing innovation and potential patent challenges.
References
[1] Patent examination records, INPI, 2017-2022.
